Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Monitoring subthalamic oscillations for 24 hours in a freely moving Parkinson's disease patient.

Arlotti M, Palmisano C, Minafra B, Todisco M, Pacchetti C, Canessa A, Pozzi NG, Cilia R, Prenassi M, Marceglia S, Priori A, Rampini P, Barbieri S, Servello D, Volkmann J, Pezzoli G, Isaias IU.

Mov Disord. 2019 May;34(5):757-759. doi: 10.1002/mds.27657. Epub 2019 Mar 20. No abstract available.

2.

Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine.

Blandini F, Cilia R, Cerri S, Pezzoli G, Schapira AHV, Mullin S, Lanciego JL.

Mov Disord. 2019 Jan;34(1):9-21. doi: 10.1002/mds.27583. Epub 2018 Dec 27. Review.

PMID:
30589955
3.

Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism.

Barichella M, Severgnini M, Cilia R, Cassani E, Bolliri C, Caronni S, Ferri V, Cancello R, Ceccarani C, Faierman S, Pinelli G, De Bellis G, Zecca L, Cereda E, Consolandi C, Pezzoli G.

Mov Disord. 2019 Mar;34(3):396-405. doi: 10.1002/mds.27581. Epub 2018 Dec 21.

PMID:
30576008
4.

Multiparametric MR imaging of Parkinsonisms at 3 tesla: Its role in the differentiation of idiopathic Parkinson's disease versus atypical Parkinsonian disorders.

Calloni SF, Conte G, Sbaraini S, Cilia R, Contarino VE, Avignone S, Sacilotto G, Pezzoli G, Triulzi FM, Scola E.

Eur J Radiol. 2018 Dec;109:95-100. doi: 10.1016/j.ejrad.2018.10.032. Epub 2018 Nov 1.

PMID:
30527319
5.

Molecular Imaging of the Cannabinoid System in Idiopathic Parkinson's Disease.

Cilia R.

Int Rev Neurobiol. 2018;141:305-345. doi: 10.1016/bs.irn.2018.08.004. Epub 2018 Sep 7. Review.

PMID:
30314601
6.

Nutritional characterisation of Zambian Moringa oleifera: acceptability and safety of short-term daily supplementation in a group of malnourished girls.

Barichella M, Pezzoli G, Faierman SA, Raspini B, Rimoldi M, Cassani E, Bertoli S, Battezzati A, Leone A, Iorio L, Ferri V, Pinelli G, Pusani C, Bolliri C, Cilia R, Caronni S, De Marco P, Cereda E.

Int J Food Sci Nutr. 2019 Feb;70(1):107-115. doi: 10.1080/09637486.2018.1475550. Epub 2018 May 24.

PMID:
29792366
7.

Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study.

Cilia R, Laguna J, Cassani E, Cereda E, Raspini B, Barichella M, Pezzoli G.

Parkinsonism Relat Disord. 2018 Apr;49:60-66. doi: 10.1016/j.parkreldis.2018.01.014. Epub 2018 Jan 11.

PMID:
29352722
8.

DNAJC12 and dopa-responsive nonprogressive parkinsonism.

Straniero L, Guella I, Cilia R, Parkkinen L, Rimoldi V, Young A, Asselta R, Soldà G, Sossi V, Stoessl AJ, Priori A, Nishioka K, Hattori N, Follett J, Rajput A, Blau N, Pezzoli G, Farrer MJ, Goldwurm S, Rajput AH, Duga S.

Ann Neurol. 2017 Oct;82(4):640-646. doi: 10.1002/ana.25048. Epub 2017 Oct 11.

PMID:
28892570
9.

Erratum to: Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.

Cereda E, Cilia R, Canesi M, Tesei S, Mariani CB, Zecchinelli AL, Pezzoli G.

J Neurol. 2017 Sep;264(9):2051. doi: 10.1007/s00415-017-8585-x. No abstract available.

10.

Opioid K receptor variant is associated with a delayed onset of dyskinesias in Parkinson's disease.

Cilia R, Asselta R, Cereda E, Benfante R, Barbella G, Vallauri D, Marabini L, Fornasari D, Goldwurm S, Pezzoli G.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):323-324. doi: 10.1136/jnnp-2017-316235. Epub 2017 Jul 19. No abstract available.

PMID:
28724719
11.

Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.

Cilia R, Laguna J, Cassani E, Cereda E, Pozzi NG, Isaias IU, Contin M, Barichella M, Pezzoli G.

Neurology. 2017 Aug 1;89(5):432-438. doi: 10.1212/WNL.0000000000004175. Epub 2017 Jul 5.

12.

Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.

Cereda E, Cilia R, Canesi M, Tesei S, Mariani CB, Zecchinelli AL, Pezzoli G.

J Neurol. 2017 Jun;264(6):1254-1263. doi: 10.1007/s00415-017-8523-y. Epub 2017 May 26. Erratum in: J Neurol. 2017 Aug 22;:.

13.

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JÁ, Cilia R, Ballanger B, Niethammer M, Stoessl JA; IPMDS-Neuroimaging Study Group.

Mov Disord. 2017 Feb;32(2):181-192. doi: 10.1002/mds.26907. Epub 2017 Feb 2. Review.

14.

Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.

Nigro S, Arabia G, Antonini A, Weis L, Marcante A, Tessitore A, Cirillo M, Tedeschi G, Zanigni S, Calandra-Buonaura G, Tonon C, Pezzoli G, Cilia R, Zappia M, Nicoletti A, Cicero CE, Tinazzi M, Tocco P, Cardobi N, Quattrone A.

Eur Radiol. 2017 Jun;27(6):2665-2675. doi: 10.1007/s00330-016-4622-x. Epub 2016 Oct 19.

PMID:
27761709
15.

Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.

Cilia R, Tunesi S, Marotta G, Cereda E, Siri C, Tesei S, Zecchinelli AL, Canesi M, Mariani CB, Meucci N, Sacilotto G, Zini M, Barichella M, Magnani C, Duga S, Asselta R, Soldà G, Seresini A, Seia M, Pezzoli G, Goldwurm S.

Ann Neurol. 2016 Nov;80(5):662-673. doi: 10.1002/ana.24777. Epub 2016 Oct 3.

PMID:
27632223
16.

Tryptophan hydroxylase type 2 variants modulate severity and outcome of addictive behaviors in Parkinson's disease.

Cilia R, Benfante R, Asselta R, Marabini L, Cereda E, Siri C, Pezzoli G, Goldwurm S, Fornasari D.

Parkinsonism Relat Disord. 2016 Aug;29:96-103. doi: 10.1016/j.parkreldis.2016.05.017. Epub 2016 May 17.

PMID:
27237108
17.

Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile.

Cassani E, Cilia R, Laguna J, Barichella M, Contin M, Cereda E, Isaias IU, Sparvoli F, Akpalu A, Budu KO, Scarpa MT, Pezzoli G.

J Neurol Sci. 2016 Jun 15;365:175-80. doi: 10.1016/j.jns.2016.04.001. Epub 2016 Apr 16.

18.

Dementia in Parkinson's disease: Is male gender a risk factor?

Cereda E, Cilia R, Klersy C, Siri C, Pozzi B, Reali E, Colombo A, Zecchinelli AL, Mariani CB, Tesei S, Canesi M, Sacilotto G, Meucci N, Zini M, Isaias IU, Barichella M, Cassani E, Goldwurm S, Pezzoli G.

Parkinsonism Relat Disord. 2016 May;26:67-72. doi: 10.1016/j.parkreldis.2016.02.024. Epub 2016 Mar 2.

PMID:
26952697
19.

Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders.

Siri C, Cilia R, Reali E, Pozzi B, Cereda E, Colombo A, Meucci N, Canesi M, Zecchinelli AL, Tesei S, Mariani CB, Sacilotto G, Zini M, Pezzoli G.

Mov Disord. 2015 Apr 15;30(5):696-704. doi: 10.1002/mds.26160. Epub 2015 Mar 11.

PMID:
25757654
20.

Swallowing disturbances in Parkinson's disease: a multivariate analysis of contributing factors.

Cereda E, Cilia R, Klersy C, Canesi M, Zecchinelli AL, Mariani CB, Tesei S, Sacilotto G, Meucci N, Zini M, Isaias IU, Cassani E, Goldwurm S, Barichella M, Pezzoli G.

Parkinsonism Relat Disord. 2014 Dec;20(12):1382-7. doi: 10.1016/j.parkreldis.2014.09.031. Epub 2014 Oct 6.

PMID:
25456827
21.

Parkinson's disease beyond 20 years.

Cilia R, Cereda E, Klersy C, Canesi M, Zecchinelli AL, Mariani CB, Tesei S, Sacilotto G, Meucci N, Zini M, Ruffmann C, Isaias IU, Goldwurm S, Pezzoli G.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):849-55. doi: 10.1136/jnnp-2014-308786. Epub 2014 Oct 3.

PMID:
25280915
22.

Glucocerebrosidase mutations in primary parkinsonism.

Asselta R, Rimoldi V, Siri C, Cilia R, Guella I, Tesei S, Soldà G, Pezzoli G, Duga S, Goldwurm S.

Parkinsonism Relat Disord. 2014 Nov;20(11):1215-20. doi: 10.1016/j.parkreldis.2014.09.003. Epub 2014 Sep 9.

23.

Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in Italy.

Italiano D, Bianchini E, Ilardi M, Cilia R, Pezzoli G, Zanettini R, Vacca L, Stocchi F, Bramanti P, Ciurleo R, Di Lorenzo G, Polimeni G, de Luise C, Ross D, Rijnbeek P, Sturkenboom M, Trifirò G.

J Neural Transm (Vienna). 2015 Jun;122(6):799-808. doi: 10.1007/s00702-014-1314-z. Epub 2014 Sep 18.

PMID:
25230720
24.

Later age at onset in Parkinson's disease over twenty years in an Italian tertiary clinic.

Pezzoli G, Klersy C, Cilia R, Canesi M, Zecchinelli AL, Mariani CB, Tesei S, Sacilotto G, Meucci N, Zini M, Isaias IU, Ruffmann C, Barichella M, Cassani E, Goldwurm S, Cereda E.

Parkinsonism Relat Disord. 2014 Nov;20(11):1181-5. doi: 10.1016/j.parkreldis.2014.08.017. Epub 2014 Sep 3.

PMID:
25219972
25.

Novel DYT11 gene mutation in patients without dopaminergic deficit (SWEDD) screened for dystonia.

Cilia R, Reale C, Castagna A, Nasca A, Muzi-Falconi M, Barzaghi C, Marzegan A, Granata M, Marotta G, Sacilotto G, Vallauri D, Pezzoli G, Goldwurm S, Garavaglia B.

Neurology. 2014 Sep 23;83(13):1155-62. doi: 10.1212/WNL.0000000000000821. Epub 2014 Aug 22.

PMID:
25150291
26.

Impulse control disorders are associated with multiple psychiatric symptoms in Parkinson's disease.

Jaakkola E, Kaasinen V, Siri C, Martikainen K, Cilia R, Niemelä S, Joutsa J.

J Parkinsons Dis. 2014;4(3):507-15. doi: 10.3233/JPD-140351.

PMID:
25112222
27.

LRRK2-G2019S mutation is not associated with an increased cancer risk: a kin-cohort study.

Allegra R, Tunesi S, Cilia R, Pezzoli G, Goldwurm S.

Mov Disord. 2014 Sep;29(10):1325-6. doi: 10.1002/mds.25969. Epub 2014 Jul 22. No abstract available.

PMID:
25048644
28.

The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.

Cilia R, Akpalu A, Sarfo FS, Cham M, Amboni M, Cereda E, Fabbri M, Adjei P, Akassi J, Bonetti A, Pezzoli G.

Brain. 2014 Oct;137(Pt 10):2731-42. doi: 10.1093/brain/awu195. Epub 2014 Jul 17.

29.

LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian population.

Cilia R, Siri C, Rusconi D, Allegra R, Ghiglietti A, Sacilotto G, Zini M, Zecchinelli AL, Asselta R, Duga S, Paganoni AM, Pezzoli G, Seia M, Goldwurm S.

Parkinsonism Relat Disord. 2014 Aug;20(8):911-4. doi: 10.1016/j.parkreldis.2014.04.016. Epub 2014 Apr 25.

30.

Reversible dopamine transporter reduction in drug-induced Parkinsonism.

Cilia R, Marotta G, Belletti A, Siri C, Pezzoli G.

Mov Disord. 2014 Apr;29(4):575-7. doi: 10.1002/mds.25828. Epub 2014 Feb 14. No abstract available.

PMID:
24532036
31.

Multiple compulsive behaviors in multiple system atrophy: the importance of predisposition to addiction.

Cilia R, Siri C, Colombo A, Pezzoli G.

Parkinsonism Relat Disord. 2014 Mar;20(3):355-7. doi: 10.1016/j.parkreldis.2013.12.010. Epub 2013 Dec 31. No abstract available.

PMID:
24423790
32.

DJ1 analysis in a large cohort of Italian early onset Parkinson Disease patients.

Sironi F, Primignani P, Ricca S, Tunesi S, Zini M, Tesei S, Cilia R, Pezzoli G, Seia M, Goldwurm S.

Neurosci Lett. 2013 Dec 17;557 Pt B:165-70. doi: 10.1016/j.neulet.2013.10.048. Epub 2013 Oct 28.

33.

Cardiometabolic factors and disease duration in patients with Parkinson's disease.

Cassani E, Cereda E, Barichella M, Madio C, Cancello R, Caccialanza R, Zini M, Cilia R, Pezzoli G.

Nutrition. 2013 Nov-Dec;29(11-12):1331-5. doi: 10.1016/j.nut.2013.04.013. Epub 2013 Sep 12.

PMID:
24035054
34.

Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.

Greenbaum L, Goldwurm S, Zozulinsky P, Lifschytz T, Cohen OS, Yahalom G, Cilia R, Tesei S, Asselta R, Inzelberg R, Kohn Y, Hassin-Baer S, Lerer B.

J Mol Neurosci. 2013 Oct;51(2):380-8. doi: 10.1007/s12031-013-0020-x. Epub 2013 May 12.

PMID:
23666822
35.

Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome.

Cilia R, Siri C, Canesi M, Zecchinelli AL, De Gaspari D, Natuzzi F, Tesei S, Meucci N, Mariani CB, Sacilotto G, Zini M, Ruffmann C, Pezzoli G.

J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):311-8. doi: 10.1136/jnnp-2012-303988. Epub 2013 Apr 16.

PMID:
23591553
36.

No association of GBA mutations and multiple system atrophy.

Srulijes K, Hauser AK, Guella I, Asselta R, Brockmann K, Schulte C, Soldà G, Cilia R, Maetzler W, Schols L, Wenning GK, Poewe W, Barone P, Wüllner U, Oertel W, Berg D, Goldwurm S, Gasser T.

Eur J Neurol. 2013 Apr;20(4):e61-2. doi: 10.1111/ene.12086. No abstract available.

PMID:
23490118
37.

Evidence of delayed nigrostriatal dysfunction in corticobasal syndrome: a SPECT follow-up study.

Ceravolo R, Rossi C, Cilia R, Tognoni G, Antonini A, Volterrani D, Bonuccelli U.

Parkinsonism Relat Disord. 2013 May;19(5):557-9. doi: 10.1016/j.parkreldis.2013.01.013. Epub 2013 Feb 20.

PMID:
23433820
38.

Nutritional status and dietary habits in Parkinson's disease patients in Ghana.

Barichella M, Akpalu A, Cham M, Privitera G, Cassani E, Cereda E, Iorio L, Cilia R, Bonetti A, Pezzoli G.

Nutrition. 2013 Feb;29(2):470-3. doi: 10.1016/j.nut.2012.09.017.

PMID:
23312767
39.

Meningioma with intense I(123) FP-CIT uptake.

Cilia R, Allegra R, Pezzoli G.

Mov Disord. 2012 Dec;27(14):1744-5. doi: 10.1002/mds.25277. No abstract available.

PMID:
23283655
40.

Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: gene and smoking status interaction.

Greenbaum L, Rigbi A, Lipshtat N, Cilia R, Tesei S, Asselta R, Djaldetti R, Goldwurm S, Lerer B.

Parkinsonism Relat Disord. 2013 Jan;19(1):72-6. doi: 10.1016/j.parkreldis.2012.07.007. Epub 2012 Aug 9.

PMID:
22884254
41.

The relationship between cerebral vascular disease and parkinsonism: The VADO study.

Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP.

Parkinsonism Relat Disord. 2012 Jul;18(6):775-80. doi: 10.1016/j.parkreldis.2012.03.017. Epub 2012 Apr 22.

PMID:
22531611
42.

The Asp620asn mutation in VPS35 is not a common cause of familial Parkinson's disease.

Guella I, Soldà G, Cilia R, Pezzoli G, Asselta R, Duga S, Goldwurm S.

Mov Disord. 2012 May;27(6):800-1. doi: 10.1002/mds.24927. Epub 2012 Jan 25. No abstract available.

PMID:
22278960
43.

Screening LRRK2 gene mutations in patients with Parkinson's disease in Ghana.

Cilia R, Sironi F, Akpalu A, Cham M, Sarfo FS, Brambilla T, Bonetti A, Amboni M, Goldwurm S, Pezzoli G.

J Neurol. 2012 Mar;259(3):569-70. doi: 10.1007/s00415-011-6210-y. Epub 2011 Aug 14. No abstract available.

PMID:
21842440
44.

Dopamine Transporter SPECT Imaging in Corticobasal Syndrome.

Cilia R, Rossi C, Frosini D, Volterrani D, Siri C, Pagni C, Benti R, Pezzoli G, Bonuccelli U, Antonini A, Ceravolo R.

PLoS One. 2011 May 2;6(5):e18301. doi: 10.1371/journal.pone.0018301.

45.

Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding.

Cilia R, van Eimeren T.

Brain Struct Funct. 2011 Nov;216(4):289-99. doi: 10.1007/s00429-011-0314-0. Epub 2011 May 4. Review.

46.

Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease.

Antonini A, Siri C, Santangelo G, Cilia R, Poletti M, Canesi M, Caporali A, Mancini F, Pezzoli G, Ceravolo R, Bonuccelli U, Barone P.

Mov Disord. 2011 Feb 15;26(3):464-8. doi: 10.1002/mds.23501. Epub 2011 Feb 10.

PMID:
21312278
47.

Pathological gambling in patients with Parkinson's disease is associated with fronto-striatal disconnection: a path modeling analysis.

Cilia R, Cho SS, van Eimeren T, Marotta G, Siri C, Ko JH, Pellecchia G, Pezzoli G, Antonini A, Strafella AP.

Mov Disord. 2011 Feb 1;26(2):225-33. doi: 10.1002/mds.23480. Epub 2011 Jan 31.

PMID:
21284039
48.

Cortical visual evoked potentials recorded after optic tract near field stimulation during GPi-DBS in non-cooperative patients.

Landi A, Pirillo D, Cilia R, Antonini A, Sganzerla EP.

Clin Neurol Neurosurg. 2011 Feb;113(2):119-22. doi: 10.1016/j.clineuro.2010.10.006. Epub 2010 Nov 20.

PMID:
21094581
49.

Sleep in genetically confirmed pantothenate kinase-associated neurodegeneration: a video-polysomnographic study.

Fantini ML, Cossu G, Molari A, Cabinio M, Uyanik O, Cilia R, Melis M, Antonini A, Ferini-Strambi L.

Parkinsons Dis. 2010 Jun 29;2010:342834. doi: 10.4061/2010/342834.

50.

A novel polymorphic AP-1 binding element of the GFAP promoter is associated with different allelic transcriptional activities.

Bachetti T, Di Zanni E, Lantieri F, Caroli F, Regis S, Filocamo M, Rainero I, Gallone S, Cilia R, Romano S, Savoiardo M, Pareyson D, Biancheri R, Ravazzolo R, Ceccherini I.

Ann Hum Genet. 2010 Nov;74(6):506-15. doi: 10.1111/j.1469-1809.2010.00614.x.

Supplemental Content

Support Center